| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
0.7515 -0.028 (-0.04%) |
09-18 16:00 |
|
Open: |
0.77 |
Pre close: |
0.7798 |
Target:
|
1.00
|
|
High: |
0.79 |
Low: |
0.7463 |
Resistance:
|
0.86
0.96
|
|
Volume: |
116,206 |
Market Cap: |
16M |
Support:
|
0.70
0.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.78
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.81 |
Signal(12,26,9): |
-0.04  |
|
MA(100): |
0.88 |
Stochastic Oscillator |
%K(14,3):
|
47.05 |
|
MA(250): |
1.04 |
%D(3): |
49.14 |
|
Average Volume(K) |
3-Month: |
44454
|
52-Week |
High:
|
2.25 |
|
10-Days: |
11870 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
35.07 |
Change(%): |
-51.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.745 |
Return on Equity (ttm) |
-1030.9 |
Shares Out. (M) |
20.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-242.9 |
Shares Float (M) |
17.75 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.45 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.87 |
|
Forward EPS |
-2.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
596 |
|
Book Value (p.s.) |
0.060 |
EBITDA (p.s.) |
-0.557 |
P/E |
-0.43 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
12.53 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.93 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.85 |
P/CF |
-1.44 |
|
|
|
|
|
|
